TLDR

Rocket Lab completed its at-the-market equity offering, selling ~6.7 million shares and raising ~$474 million in gross proceeds.
The company also entered collared forward transactions involving ~7.5 million shares, with potential proceeds between $474 million and $642 million.
Proceeds will fund future growth, potential acquisitions, and working capital.
Analyst Trevor Walsh at Citizens upgraded RKLB from Hold to Buy, keeping a price target of $85.
The average analyst price target sits at $86.77, implying ~25.6% upside from current levels.

Rocket Lab completed a $1 billion at-the-market equity offering program on Wednesday, raising roughly $474 million in gross proceeds. The stock gained around 5% on the news.

Rocket Lab USA, Inc., RKLB

The company sold approximately 6.7 million shares through at-the-market transactions. It also entered into collared forward transactions involving around 7.5 million shares.

Those forward transactions carry minimum expected proceeds of about $474 million and a maximum of roughly $642 million. Maturity dates are set for April 2028, though early settlement remains an option.

The offering program traces back to March 17, 2026, when Rocket Lab filed a prospectus supplement to sell up to $1 billion in stock. Wednesday’s completion wraps up that process.

Rocket Lab said it plans to use the net proceeds for future growth, including potential acquisitions, and for general corporate and working capital purposes. No specific acquisition targets were named.

The stock move came on a broadly positive day for equity markets, which provided a helpful backdrop.

Analyst Upgrades Fuel Optimism

Earlier this week, Citizens analyst Trevor Walsh upgraded RKLB from Hold to Buy. He kept his price target at $85, which implies roughly 25% upside from current levels.

Walsh pointed to current price levels as a strong entry point. He also cited Rocket Lab’s push into defense and space services as a path to higher margins and more stable revenue.

Walsh flagged the anticipated SpaceX IPO — potentially valued at $2 trillion — as a catalyst that could pull broader investor attention toward the space sector.

Roth MKM analyst Sujeeva De Silva reaffirmed a Buy rating with a $90 price target. De Silva highlighted the company’s growing backlog and its expansion into building satellite components.

De Silva described Rocket Lab as “successfully diversifying into Space Systems,” moving beyond launches. He sees that backlog as evidence of strong growth potential.

Across TipRanks, RKLB holds a Moderate Buy consensus rating. That comes from 10 Buy ratings and five Holds over the last three months.

The average price target across those analysts is $86.77, suggesting about 25.6% upside from current trading levels.

Neutron Rocket Remains a Key Watch

Beyond the capital raise, Rocket Lab’s Neutron rocket continues to attract attention. The 43-meter, partially reusable vehicle is designed for satellite launches and cargo missions.

Key components — including the “Hungry Hippo” fairing and thrust structure — are ready for final assembly. A first launch is expected in late 2026 or early 2027.

Clear Street analyst Gregory Pendy noted that Neutron could address a larger market than Electron and generate higher revenue per mission. That makes it a key growth lever for the company.

Rocket Lab’s stock has been volatile in 2026, with limited net gains year-to-date. The average analyst price target currently sits at $86.77.

The post Rocket Lab (RKLB) Stock Jumps 5% — And Analysts Think There’s More Room to Run appeared first on CoinCentral.

---

Filed under: News - @ April 9, 2026 1:27 pm